Interspecies scaling: Predicting volumes, mean residence time and elimination half-life. Some suggestions

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 5, 1998, Pages 493-499

  Mahmood, Iftekhar ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 CARBAMOYLOXYETHYLTHIO) 6 (1 HYDROXYETHYL)PENEM 3 CARBOXYLIC ACID; ACIVICIN; AMPHOTERICIN B; AMSACRINE; ASULACRINE ISETHIONATE; CAFFEINE; CEFAZOLIN; CEFMETAZOLE; CEFOPERAZONE; CEFOTETAN; CEFPIRAMIDE; CIPROFLOXACIN; CYCLOSPORIN; ERYTHROMYCIN; ETHOSUXIMIDE; INTERFERON; LAMIFIBAN; LATAMOXEF; OLEANDOMYCIN; PHENAZONE; REMOXIPRIDE; SEMATILIDE; THEOPHYLLINE; TOLCAPONE; TOPIRAMATE; VALPROIC ACID; WARFARIN; ZIDOVUDINE;

ALLOMETRY; ARTICLE; BODY WEIGHT; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; RAT; SPECIES DIFFERENCE; STEADY STATE;

EID: 0031744805     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb06190.x     Document Type: Article

References (36)

1. Abadia, A. R., Aramayona, J. J., Munoz, M. J., Pladelfina, J. M., Saez, M. P., Bregante, M. A. (1994) Disposition of ciprofloxacin following intravenous administration in dogs. J. Vet. Pharmacol. Ther. 17: 384-388
2. Aramayona, J. J., Mora, J., Fraile, L. J., Garcia, M. A., Abadia, A. R., Bregante, M. A. (1996) Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring. Am. J. Vet. Res. 57: 547-553
3. Awani, W. M., Sawchuk, R. J. (1985) The pharmacokinetics of cyclosporin. I. Single dose and constant rate infusion in the rabbit. Drug. Metab. Dispos. 13: 127-132
4. Bachmann, K. (1989). Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species. J. Appl. Toxicol. 9: 331-338
5. Bonati, M., Latini, R., Tognoni, G. (1984-85) Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse. Drug. Metab. Rev. 15: 1355-1383
6. Boxenbaum, H. (1982) Interspecies scaling, allometry, physiological time and the ground plan of pharmacokinetics. J. Pharmacokin. Biopharm. 10: 201-227
7. Boxenbaum, H. (1984). Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug. Metab. Rev. 15: 1071-1121
8. Boxenbaum, H., Fertig, J. B. (1984) Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species. Eur. J. Drug. Metab. Pharmacokin. 9: 177-183
9. Chung, M., Radwanski, E., Loebenberg, D., Lin, C., Oden, E., Symchowicz, S., Gural, R. P., Miller, G. H. (1985) Interspecies pharmacokinetic scaling of Sch 34343. J. Antimicrob. Chemother. 15 (Suppl. C): 227-233
10. Drusano, G. L., Plaisance, K. I. A., Standiford, H. C. (1986) Dose ranging study and constant infusion evaluation of ciprofloxacin. Antimicrob. Agents. Chemother. 30: 440-443
11. Duthu, G. S. (1985) Interspecies correlation of the pharmacokinetics of erythromycin, oleandomycin, and tylosin. J. Pharm. Sci. 74: 943-946
12. El Sayed, M. A., Loscher, W., Frey, H. H. (1978) Pharmacokinetics of ethosuximide in the dog. Arch. Int. Pharmacodyn. 234: 180-192
13. Gascon, R. A., Calvo, B., Hernandez, R. M., Dominguez-Gil, A., Pedraz, J. (1994) Interspecies scaling of cimetidine-theophylline pharmacokinetic interaction: interspecies scaling in pharmacokinetic interaction. Pharm. Res. 11: 945-950
14. Gridelli, B., Scanlon, L., Pellicci, R., Lapointe, R., Dewolf, A., Seltman, H., Diven, W., Shaw, B., Starzi, T., Sanghvi, A. (1986) Cyclosporin metabolism and pharmacokinetics following intravenous and oral administration in the dog. Transplantation 41: 388-391
15. Hinderling, P. H., Dilea, C., Koziol, T., Millington, G. (1993) Comparative kinetics of sematilide in four species. Drug. Metab. Dispos. 21: 662-669
16. Houston, B. (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 47: 1469-1479
17. Hutchaleelaha, A., Chow, H., Mayersohn, M. (1997) Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species. J. Pharm. Pharmacol. 49: 178-183
18. Lave, T., Levet-Traft, B., Schmitt-Hoffmann, A. H., Morgenroth, B., Richter, W., Chou, R. C. (1995) Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations. J. Pharm. Sci. 84: 1285-1290
19. Lave, T., Saner, A., Coassolo, P., Brandt, R., Schmitt-Hoffmann, A. H., Chou, R. C. (1996a) Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor. J. Pharm. Pharmacol. 48: 573-577
20. Lave, T., Dupin, S., Schmitt, M., Kapps, M., Meyer, J., Morgenroth, B., Chou, R. C., Jaeck, D., Coassolo, P. H. (1996b) Interspecies scaling of tolcapone, a new inhibitor of catechol-O-methyltransferase (COMT). Use of in vitro data from hepatocytes to predict metabolic clearance in animals and humans. Xenobiotica 26: 839-851
21. Lave, T., Dupin, S., Schmitt, C., Chou, R. C., Jaeck, D., Coassolo, P. H. (1997) Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. J. Pharm. Sci. 86: 584-590
22. Lindstedt, S. L., Calder III, W. A. (1981) Body size, physiological time, and longevity of homeothermic animals. Q. Rev. Biol. 56: 1-16
23. Loscher, W. (1978) Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse. J. Pharmacol. Exp. Ther. 204: 255-261
24. Mahmood, I., Balian, J. D. (1996a) Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance. J. Pharm. Sci. 85: 411-414
25. Mahmood, I., Balian, J. D. (1996b) Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica 26: 887-895
26. McGovern, J. P., Williams, M. G., Stewart, J. C. (1988) Interspecies comparison of acivicin pharmacokinetics. Drug. Metab. Dispos. 16: 18-22
27. McNamara, P. G. (1991) Interspecies scaling in pharmacokinetics. In: Welling, P. G., Tse, F. L. S., Dighe, S. V. (eds) Pharmaceutical Bioequivalence. Marcel Dekker, New York
28. Movin-Osswald, G., Hammarlund-udenaes, M. (1991) Remoxipride: pharmacokinetics and effect on plasma prolactin. Br. J. Clin. Pharmacol. 32: 355-360
29. Patel, B. A., Boudinot, F. D., Schinazi, R. F., Gallo, J. M., Chu, C. K. (1990) Comparative pharmacokinetic and interspecies scaling of 3′-azido-3′-deoxythymidine (AZT) in several mammalian species. J. Pharmacobio-Dyn. 13: 206-211
30. Paxton, J. W., Kim, S. N., Whitfield, L. R. (1990) Pharmacokinetic and toxicity of the antitumor agents amascrine and CI-921, a new analogue, in mice, rats, rabbits, dogs and humans. Cancer Res. 50: 2692-2697
31. Sangali, L., Bortollotti, A., Jiritano, L., Bonati, M. (1988). Cyclosporin pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans. Drug. Metab. Dispos. 16: 749-753
32. Shargel, L., Yu, A. B. C. (1993) Applied Biopharmaceutics and Pharmacokinetics. 3rd edn, Appleton and Lange, Stamford, Connecticut
33. Siefert, H. M., Maruhn, D., Maul, W., Forster, D., Ritter, W. (1986) Pharmacokinetics of ciprofloxacin. Arzneim. Forsch. 36: 1496-1502
34. Swada, Y., Hanano, M., Sugiyama, Y., Iga, T. (1984) Prediction of the disposition of β-lactam antibiotics in humans from pharmacokinetic parameters in animals. J. Pharmacokin. Biopharm. 12: 241-261
35. Widman, M., Nilsson, L. B., Bryske, B., Lundstrom, J. (1993) Disposition of remoxipride in different species. Species differences in metabolism. Arzneim. Forsch. 43: 287-297
36. Wise, R., Lockley, R. M., Webberly. M., Dent, J. (1984) Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrob. Agents Chemother. 26: 208-210